Clinical Trial Update: EFFICACY AND SAFETY OF A SIMPLIFICATION STRATEGY BASED ON DOLUTEGRAVIR AND DARUNAVIR / COBICISTAT VS OPTIMIZED TREATMENT IN SUPPRESSED HIV-1-INFECTED PATIENTS CARRYING ARCHIVED MULTIDRUG RESISTANCE MUTATIONS [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating a simplification strategy using dolutegravir and darunavir/cobicistat versus optimized treatment in suppressed HIV-1 patients with arch…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Dolutegravir (dolutegravir)
• darunavir/cobicistat (darunavir/cobicistat)

Snippet

Sponsor: Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia | Conditions: HIV-1 Infection | Phase 4 | Status: COMPLETED